Glucose Monitoring Devices Market Size Grows at a Staggering CAGR of 5.63%

Introduction

Straits Research released its highly anticipated report, “Global Glucose Monitoring Devices Market Size & Outlook, 2026-2034”. According to the study, the global market size is valued at USD 13.88 billion in 2025 and is projected to expand to USD 22.64 billion by 2034, registering a compound annual growth rate (CAGR) of 5.63%.

Market Dynamics

The growth of the global glucose monitoring devices market is driven by the increasing prevalence of type 2 diabetes worldwide, coupled with growing awareness of the importance of effective blood glucose management. According to the International Diabetes Federation (IDF) 2025 Report, approximately 531 million people are living with type 2 diabetes, a figure projected to rise to 853 million by 2050, thereby creating sustained demand for glucose monitoring solutions. Technological advancements, such as real-time continuous glucose monitoring (CGM) systems and implantable sensors, are further enhancing patient convenience and accuracy in tracking blood sugar levels. Moreover, supportive government initiatives and reimbursement frameworks across developed regions are encouraging broader adoption of advanced monitoring devices.

However, device calibration complexities and data privacy concerns associated with digital health integration pose challenges for manufacturers and healthcare providers and restrain the glucose monitoring devices market growth. On the other hand, opportunities lie in the rapid expansion of telehealth services and remote patient monitoring programs, which are enabling broader integration of glucose monitoring devices into routine diabetes care. Moreover, increasing partnerships between medtech firms and digital health companies are strengthening device connectivity, fostering innovation, and creating a pathway toward personalized diabetes management on a global scale during the forecast period.

Market Highlights

• Product: The continuous glucose monitoring devices segment is expected to register the fastest CAGR of 6.32%.
• Application: According to Straits Research, the type 2 segment dominated the market with a revenue share of 68.43% in 2025, owing to growing awareness of proactive glucose management and rising adoption of continuous glucose monitoring devices
• End User: The home care settings segment is estimated to register the fastest CAGR of 6.29%.
• Regional Insights: North America dominated the market, accounting for 38.14% share in 2025, owing to strong adoption of advanced continuous glucose monitoring devices and favorable reimbursement policies.

Competitive Players

1. Braun SE
2. Senseonics, A.
3. DexCom, Inc.
4. Abbott
5. GlySens Incorporated
6. Menarini Diagnostics S.R.L.
7. Hoffman-La Roche Ltd.
8. Johnson & Johnson
9. Medtronic plc
10. Ascensia Diabetes Care
11. Ypsomed
12. Prodigy Diabetes Care
13. Nipro
14. Nova Biomedical
15. ACON Laboratories, Inc.
16. Sinocare
17. ForaCare, Inc.
18. Trividia Health, Inc.
19. AgaMatrix
20. Beurer GmbH

Recent Developments

Segmentation

1. By Product (2026-2034)
   1. Self-monitoring Devices
      1. Blood Glucose meters
      2. Testing strips
      3. Lancets & Lancing Devices
   2. Continuous Glucose Monitoring Devices
      1. Sensors
      2. Transmitters & Receivers
      3. Insulin Pump
2. By Application (2026-2034)
   1. Type 1 Diabetes
   2. Type 2 Diabetes
   3. Others
3. By End User (2026-2034)
   1. Hospitals & Clinics
   2. Home Care Settings
   3. Others